Ppara, but not Cpt1a, was significantly upregulated by HFHC feeding in the clodronate-treated group but not in the vehicle-treated group, which might in part have contributed toward the attenuation of steatosis by activating β-oxidation. This evidence concerns the gene PPARA and steatosis.